Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

UCB SA

UCBJYPNK
Healthcare
Biotechnology
$159.87
$0.003(0.002%)
U.S. Market opens in 9h 40m

UCB SA (UCBJY) Stock Overview

Explore UCB SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap60.6B
P/E Ratio39.32
EPS (TTM)$4.04
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$163.36
3 Months$150.80
1 Year Target$176.74

UCBJY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of UCB SA (UCBJY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.87, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $176.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 39.32 and a market capitalization of 60.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.32%
5-Day Change
-2.99%
1-Month Change
4.81%
3-Month Change
16.55%
6-Month Change
36.55%
Year-to-Date (YTD) Change
15.99%
1-Year Change
63.40%
3-Year Change
265.48%
5-Year Change
205.33%
All-Time (Max) Change
962.33%

Contact Information

32 2 559 99 99
Allée de la Recherche, 60, Brussels, 1070

Company Facts

9,052 Employees
IPO DateAug 3, 2012
CountryBE
Actively Trading

Frequently Asked Questions